Medical Electronics PCB Manufacturing Guide

Medical electronics PCB manufacturing requires more than placing components on a circuit board.
Design decisions affect fabrication, soldering, inspection, test coverage, traceability and later
production control. RLX Solutions, a contract electronics manufacturer in Concord, Ontario,
reviews those interactions before a medical electronics build moves from files to finished assemblies.

A medical programme also needs a clear distinction between the quality system surrounding the build
and the workmanship requirements applied to the product. ISO 13485 addresses quality management for
medical devices. IPC standards address areas such as PCB fabrication, soldering and assembly workmanship.
They overlap operationally, but they are not substitutes for one another.

For an OEM, that distinction matters because the manufacturing package must translate device requirements
into measurable fabrication, assembly, inspection and test instructions. For other sectors, see our guide to PCB applications by industry.

Start With the Product Requirements, Not the PCB Quote

A contract manufacturer can build only to the requirements communicated in the manufacturing package.
For medical electronics, that package should resolve several questions before production:

• What IPC workmanship class applies?
• Which assemblies, components and materials require lot or date-code traceability?
• Which electrical functions must be verified before shipment?
• Are hidden solder joints present under ball grid array (BGA), land grid array (LGA) or quad flat no-lead (QFN) packages?
• Does the board require conformal coating, underfill or encapsulation?
• Are moisture-sensitive devices involved?
• Are any obsolete, allocated or authenticity-sensitive components on the bill of materials (BOM)?
• Which characteristics require customer approval at first article?

These decisions change the production route.

For example, specifying a BGA without defining suitable inspection leaves an important part of the
solder joint inaccessible to ordinary visual inspection. Specifying a functional test without a test
procedure, fixture interface or expected limits creates a similar gap at the end of the line.

Design for manufacturability and design for assembly (DFM/DFA) should therefore happen before release,
rather than after a lot exposes an avoidable problem.

Medical PCB Manufacturing Is a Chain of Controlled Processes

The bare PCB is one part of the finished medical electronics assembly. Fabrication choices determine
what the assembly process receives, while assembly choices determine how thoroughly the finished product
can be inspected and tested.

A typical flow contains these linked stages:

1. Engineering and DFM/DFA review.
   Stackup, footprints, clearances, package choices, assembly access and manufacturing files are reviewed before release.
2. Bare PCB fabrication.
   Lamination, drilling, plating, imaging, solder mask and surface finish create the printed circuit board.
3. Component procurement and incoming inspection.
   Parts are sourced, identified, inspected and controlled before placement.
4. Solder paste inspection and placement.
   Paste deposition is checked before components pass through reflow.
5. Post-reflow inspection.
   Automated optical inspection (AOI), manual inspection and X-ray are applied according to package geometry and workmanship requirements.
6. Electrical and functional test.
   Net connectivity, device programming and product functions are tested according to the build plan.
7. First article approval and lot release.
   The initial build establishes whether manufacturing output matches the approved documentation before the remaining production lot is released.

A weakness at one stage can surface much later. Excess solder paste on a QFN thermal pad, for example,
may become an X-ray finding after reflow. A footprint issue may first appear as repeated solder defects.
An insufficient test strategy may allow an electrically assembled board to pass inspection even though
a functional circuit is incorrect. Related reading: Consumer Electronics PCB Manufacturing Guide.

IPC Class 2 and Class 3 Change the Manufacturing Expectation

IPC-A-610 defines electronic assembly acceptability criteria, while IPC-6012 addresses qualification
and performance requirements for rigid printed boards. J-STD-001 addresses soldered electrical and
electronic assemblies.

Class 2 and Class 3 should not be treated as marketing labels. The selected class changes the workmanship
and acceptance expectations applied to the product.

Class 2 is associated with dedicated-service electronic products where continued performance is expected,
but uninterrupted operation is not the defining requirement. Class 3 applies tighter acceptance expectations
for high-performance or high-reliability electronics where continued performance can be especially important.

For PCB fabrication, Class 3 also brings tighter expectations around features such as annular rings and plating.
At assembly, the effect reaches solder joints, placement, inspection and documentation.

The manufacturer needs the required class defined in the documentation. Leaving it to inference introduces
ambiguity into inspection and acceptance.

Do Not Confuse ISO 13485 With IPC Class 3

ISO 13485 and IPC Class 3 answer different questions.

ISO 13485 is a medical-device quality-management framework. IPC Class 3 is a product workmanship and performance
classification. A programme can require quality-system controls while separately defining its PCB fabrication
and assembly workmanship criteria.

An ISO 13485-aligned manufacturing process therefore does not automatically make a circuit board Class 3,
and a Class 3 build does not by itself establish ISO 13485 certification.

That distinction should appear in supplier qualification documents, drawings, purchase requirements and
quality agreements rather than being assumed from the word “medical.”

PCB Stackup Decisions Affect Reliability Before Assembly Starts

Medical electronics do not automatically require a high layer count or high-density interconnect (HDI).
The stackup should follow electrical, mechanical and routing requirements.

A four-layer control board with ordinary through vias may be easier to fabricate and inspect than an
eight-layer board using blind vias and via-in-pad structures. The second board can still be the correct design,
but it creates additional process dependencies.

Blind vias on a multilayer board require sequential lamination because the via must connect selected layers
rather than pass through the complete finished stack. Via-in-pad plated over structures add resin filling,
copper capping and planarization. Laser-drilled microvias introduce another drilling and plating route.

Those decisions should be intentional.

Worked Example: Two 10-Layer Medical Boards

Consider two hypothetical 10-layer PCB designs with the same outline and 1.6 mm finished thickness.

Decision Factor	Board A	Board B
Layer count	10 layers	10 layers
Via structure	Through vias	Layer 1 to 2 microvias, Layer 2 to 3 microvias, buried Layer 3 to Layer 8 vias
BGA escape	Conventional dog-bone routing	Via-in-pad under dense BGA
Lamination	Conventional multilayer sequence	Sequential lamination required
Via processing	Mechanical drilling and plating	Laser drilling, internal via processing, filling and capping
Manufacturing consequence	Fewer dependent process stages	More drilling, plating, lamination and planarization stages

The two boards have identical layer counts, yet they should not be expected to carry the same manufacturing
cost or process risk.

Board B needs additional fabrication stages because its interconnect architecture is built in separate layer groups.
A defect introduced early in the sequence can affect material that has already undergone several processing steps.
Board A avoids those stages because the through holes are drilled after the multilayer structure is formed.

Layer count is therefore a poor purchasing proxy when used alone.

Aspect Ratio Becomes Important on Small Holes and Thick Boards

A plated-through-hole aspect ratio is the relationship between PCB thickness and drilled hole diameter.
As the board becomes thicker or the hole becomes smaller, depositing plating uniformly through the barrel
becomes more demanding.

Consider a hypothetical 2.0 mm thick board with a 0.20 mm plated hole. Its nominal thickness-to-hole relationship
is 10:1.

Change only the hole diameter to 0.15 mm and the relationship increases to roughly 13.3:1.
The PCB still looks similar in CAD, but the plating problem has changed substantially.

This is why via diameter, finished thickness and plating expectations must be evaluated together.
Reducing a via because routing is congested is not an isolated layout decision.

If the design is approaching a fabrication boundary, alternatives may include increasing the drilled diameter,
reducing finished board thickness, changing the via architecture or revisiting routing density.

Surface Finish Connects Fabrication to Solderability

Surface finish protects exposed copper and creates the interface that assembly will solder to.

Common options include hot air solder levelling (HASL), electroless nickel immersion gold (ENIG),
electroless nickel electroless palladium immersion gold (ENEPIG), immersion silver, immersion tin and
organic solderability preservative (OSP).

The selection should reflect the assembly and product requirements rather than appearance.

Fine-pitch surface-mount pads generally benefit from a flat finish because component coplanarity and paste
deposition are sensitive to pad geometry. Wire bonding changes the finish requirement again. OSP can make
sense for suitable single-reflow builds, but the expected assembly sequence and handling should be considered
before it is specified.

The engineering question is therefore not “Which finish is best?” It is “Which finish supports the component
terminations, assembly sequence, storage plan and downstream processes on this board?”

Inspection Must Match the Failure Mode

No single inspection technology sees every defect.

Solder paste inspection (SPI) measures paste before reflow, including parameters such as volume, area and offset.
Catching a stencil-printing problem at this point prevents defective deposits from travelling further through assembly.

AOI examines visible features after reflow. It is useful for component presence, orientation, placement and visible
solder conditions.

X-ray inspection addresses a different visibility problem. Solder joints beneath BGAs, LGAs and QFNs cannot be
fully evaluated from the surface, so X-ray can examine hidden interconnects and conditions such as voiding.

Manual visual inspection under magnification remains relevant because acceptance still requires judgement against
the applicable workmanship criteria.

Worked Example: 0.5 mm Pitch BGA Versus Visible Gull-Wing Leads

Take a hypothetical six-layer diagnostic interface board containing two packages:

• a 0.5 mm pitch BGA with 196 balls;
• a gull-wing connector interface with visible soldered leads.

Both devices pass through the same reflow process, but their inspection paths differ.

AOI can inspect visible features around the BGA package, but the solder balls are underneath the body.
X-ray is therefore the process that gives access to the hidden joint pattern. The gull-wing leads, by comparison,
expose their solder fillets to optical and manual inspection.

The package architecture determines the useful inspection method. Calling for “100% inspection” without naming
the method can still leave the most relevant defect mechanism unseen.

Testing Answers Questions That Inspection Cannot

Inspection determines whether manufacturing features appear acceptable. Electrical test determines whether
connections and functions behave as intended.

Flying-probe in-circuit test (ICT) can be useful for prototypes and lower volumes because it does not require
a dedicated bed-of-nails fixture. Production programmes may justify fixture-based ICT where repeated access
to test nodes is available.

Functional test (FCT) addresses a different level of verification. It exercises the finished electronics against
a customer-defined procedure and can record pass/fail results against serialised assemblies.

Those methods should be planned during design.

If an engineer routes every useful test node under inaccessible components, ICT coverage becomes harder.
If the functional-test procedure requires a programming header that was removed to save board area,
the manufacturing problem was created in layout.

Design for test is therefore part of design for manufacturing.

Traceability Begins With Components, Not the Final Label

Medical electronics programmes often need records that connect finished assemblies to the material and
processes used to build them.

Useful traceability can include component lot codes, date codes, process documentation, serialisation and test records.
The value is relational. A serial number on the finished enclosure adds little if it cannot be linked back to the
production records needed for investigation.

Moisture-sensitive device control is another part of that chain. IPC/JEDEC J-STD-033 governs handling practices
for moisture-sensitive devices. Dry storage and appropriate handling help control the risk of moisture-related
package damage during soldering.

Electrostatic discharge (ESD) control similarly protects sensitive components before failures become visible
at end-of-line test.

These controls matter because latent damage may not present as an obvious assembly defect.

Component Procurement Is Part of Medical Electronics Risk Control

A technically correct PCB design can still inherit risk through the supply chain.

Authorized distribution gives a strong procurement path, but medical programmes can remain in production long enough
for parts to become allocated, obsolete or end-of-life. That is where sourcing discipline and authenticity verification
become relevant.

A counterfeit-prevention workflow can include:

• source vetting;
• packaging and moisture-bag inspection;
• date-code and country-of-origin verification;
• visual inspection using IDEA-STD-1010 criteria;
• lot verification against manufacturer production records;
• X-ray examination of die and bond-wire construction;
• sample electrical, curve-trace or parametric testing;
• escalation to decapsulation and die analysis when required.

The mechanism is important. A package can carry convincing external markings while containing an incorrect die,
recycled material or a part outside the required electrical characteristics. Visual inspection alone cannot resolve
every authenticity question.

For long-life medical products, approved-alternative planning and lifecycle monitoring should therefore begin before
a component disappears from normal distribution.

Protective Coatings and Encapsulation Need Design Input

Conformal coating, underfill and potting solve different problems.

Conformal coating applies a protective polymer layer over the assembled circuit board. Acrylic, silicone,
polyurethane and parylene processes can be applied selectively or across larger board areas depending on
the programme requirements.

Underfill places material beneath components to alter mechanical support and stress behaviour. It is commonly
associated with packages where the solder interconnect sits beneath the component.

Potting or encapsulation surrounds larger areas of an assembly in protective material.

These processes affect manufacturing access. Connectors, test points, programming pads, switches, pressure interfaces
or other keep-out features may need masking or exclusion. If coating requirements arrive after layout release,
the manufacturer may be forced to solve access and masking problems that could have been designed out earlier.

First Article Approval Separates Process Setup From Production Release

A first article inspection (FAI) gives the OEM an opportunity to assess a new build before the production lot proceeds.

The important point is not merely that one assembly is inspected. The first article is where the released fabrication
package, BOM, placement data, assembly drawing, workmanship requirements, programming instructions and test plan meet
the actual manufacturing process.

If the first article reveals a footprint polarity error, inaccessible test node or documentation conflict,
the issue can be resolved before the same problem is repeated across the lot.

For a new medical electronics build, customer approval of the first article should therefore be treated as a production
gate, not an administrative formality.

Give the Manufacturer a Complete Release Package

A complete release package reduces interpretation during quoting and production.

For the bare PCB, manufacturing data can include:

• Gerber RS-274X, ODB++ or IPC-2581 data;
• NC drill files;
• stackup information;
• impedance targets;
• fabrication notes.

For assembly, add:

• BOM in spreadsheet or CSV form;
• pick-and-place or centroid data;
• assembly drawing;
• applicable workmanship class;
• programming requirements;
• test procedure and acceptance criteria;
• serialisation requirements;
• coating or encapsulation instructions where applicable.

Native design files can also support engineering review when design work or deeper troubleshooting is required.

File completeness affects more than administrative speed. An omitted polarity indication can become an assembly ambiguity.
Missing impedance information can affect fabrication engineering. A BOM without manufacturer part numbers can create
procurement interpretation that should have been resolved by the designer.

Build the Quality Plan Around the Actual Medical Product

A small monitoring accessory, a laboratory instrument controller and electronics intended for a high-reliability
medical function do not create identical manufacturing risks.

The quality plan should follow the actual product requirements: applicable workmanship class, component risk,
hidden-joint inspection, traceability depth, electrical test, functional verification and protective processing.

A useful manufacturing review connects each requirement to a process that can produce objective evidence.

For example, a requirement for hidden BGA joint inspection points toward X-ray. A requirement for serial-level
functional history points toward logged FCT and serialisation. A requirement for controlled bare-board impedance
points toward coupon verification by time-domain reflectometry (TDR).

The specification becomes meaningful when each requirement has a manufacturing mechanism behind it.

Prepare the Build for Engineering Review

If you are preparing a medical electronics board for prototype, pilot or production release, RLX can review the
design and manufacturing package as part of the quoting process. Send the Gerbers or other manufacturing data,
BOM, pick-and-place file, drawings, stackup requirements and test information so the PCB, assembly, sourcing and
verification requirements can be assessed together.

Frequently Asked Questions

Does a medical PCB have to be IPC Class 3?

Not automatically. The required workmanship class comes from the product and programme requirements.
IPC Class 2 and Class 3 impose different acceptance expectations, with Class 3 applying tighter criteria.
The OEM should define the required class in the fabrication and assembly documentation rather than expecting
the manufacturer to infer it from the product being medical.

Is RLX ISO 13485 certified?

RLX operates ISO 13485-aligned processes for medical programmes. ISO 13485 alignment should not be described
as ISO 13485 certification. The company holds ISO 9001:2015 certification, while medical manufacturing requirements
can incorporate ISO 13485-aligned controls alongside the applicable PCB fabrication, assembly, inspection and
traceability requirements.

What inspection is used for BGAs on medical electronics?

BGA solder joints are hidden beneath the package, so surface inspection cannot fully evaluate them.
X-ray inspection can examine BGA, LGA and QFN joints and support void analysis. That inspection can be combined
with solder paste inspection before reflow, automated optical inspection after reflow and manual IPC-A-610
visual inspection as applicable to the assembly.

Can medical PCB assemblies be functionally tested?

Yes. Functional test can be performed to a customer-defined specification, with pass/fail logging tied to serial
traceability. The OEM needs to provide the expected test procedure and acceptance criteria. Test access should
be considered during layout because connector access, programming interfaces and test-point placement can determine
how efficiently the finished assembly can be verified.

What files are needed to quote a medical electronics PCB assembly?

A useful assembly package includes the bare-board manufacturing data, NC drill data, BOM, pick-and-place or centroid
file, assembly drawing and relevant fabrication notes. Stackup and impedance requirements should also be included
where applicable. Programming, functional-test, serialisation, coating and workmanship requirements should be supplied
when they form part of the production scope.

How should obsolete medical electronics components be sourced?

The sourcing route should preserve authenticity and traceability while addressing availability. Authorized distribution
is one channel, while constrained or obsolete parts may require vetted independent sources. Higher-risk material can
undergo packaging inspection, IDEA-STD-1010 visual inspection, lot verification, X-ray and electrical testing, with
further analysis used when authenticity cannot otherwise be established.